Status:

COMPLETED

A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment

Lead Sponsor:

Tibotec Pharmaceuticals, Ireland

Conditions:

Hepatitis C

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine the efficacy, safety and tolerability of different regimens of TMC435 with standard treatment compared to standard treatment alone in participants with chroni...

Detailed Description

The study is a randomized (study drug assigned by chance), double-blind (neither physician nor participant knows the name of the assigned drug), placebo-controlled Phase IIb trial with TMC435 in parti...

Eligibility Criteria

Inclusion

  • Must have chronic hepatitis C infection as evidenced by liver biopsy, anti-hepatitis C virus (HCV) and HCV RNA positive
  • Must have chronic hepatitis C infection (genotype 1) with HCV RNA level greater than10000 IU/mL
  • Patient must have failed at least 1 prior course of peg interferon (Peg-IFN-alfa-2a)/ribavirin (RBV) therapy (standard treatment)
  • Must be willing to use 2 effective methods of birth control for up to 7 months after last dose of study medication

Exclusion

  • Has an evidence of decompensated liver disease
  • Co-infection with any other Hepatitis C virus genotype or co-infection with the human immunodeficiency virus (HIV)
  • Has a medical condition which is a contraindication to Peg-INF or RBV therapy
  • Have had history of, or any current medical condition which could impact the safety of the patient in the study

Key Trial Info

Start Date :

October 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2011

Estimated Enrollment :

463 Patients enrolled

Trial Details

Trial ID

NCT00980330

Start Date

October 1 2009

End Date

August 1 2011

Last Update

June 9 2014

Active Locations (78)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 20 (78 locations)

1

La Jolla, California, United States

2

Los Angeles, California, United States

3

Jacksonville, Florida, United States

4

Miami, Florida, United States